ST
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
0.044
Exchange
XLON - London Stock Exchange
-0.0036 B
Last period CFO ,GBP
-346%
CFO has decreased in 5 years
What is CFO ?
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
See also Shield Therapeutics
Company Analysis
STX.L valuation, rating, competitors, insights and company profile
Eyestock Rating
STX.L financial analysis by Eyestock methodology
Valuation
STX.L valuation using historical relative method
Statements
STX.L Income Statements, Balance Sheet and Cash Flow Statements
Dividends
STX.L dividend yield and annual dividend
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
Shield Therapeutics`s CFO for the period ended 2024-06-30 is -0.0036 B GBP
